Risk factors for the development of depression in patients with hepatitis C taking interferon-α

References

• ShepardCWFinelliLAlterMJGlobal epidemiology of hepatitis C virus infectionLancet Infect Dis20055955856716122679
   PubMed Web of Science ®Google Scholar
• PoynardTYuenMFRatziuVLaiCLViral hepatitis CLancet200336294012095210014697814
   PubMed Web of Science ®Google Scholar
• EstebanJISauledaSQuerJThe changing epidemiology of hepatitis C virus infection in EuropeJ Hepatol200848114816218022726
   PubMed Web of Science ®Google Scholar
• RantalaMvan de LaarMJSurveillance and epidemiology of hepatitis B and C in Europe – a reviewEuro Surveill20081321 Available from: http://www.eurosurveillance.org/ViewArticle.aspx?ArticleId=18880. Accessed 2010 Sep 18.
   Google Scholar
• AlterMJEpidemiology of hepatitis C virus infectionWorld J Gastroenterol200713172436244117552026
   PubMed Web of Science ®Google Scholar
• AlazawiWCunninghamMDeardenJFosterGRSystematic review: outcome of compensated cirrhosis due to chronic hepatitis C infectionAliment Pharmacol Ther201032334435520497143
   PubMed Web of Science ®Google Scholar
• LeoneNRizzettoMNatural history of hepatitis C virus infection: from chronic hepatitis to cirrhosis, to hepatocellular carcinomaMinerva Gastroenterol Dietol2005511314615756144
   PubMedGoogle Scholar
• PatelKMuirAJMcHutchisonJGDiagnosis and treatment of chronic hepatitis C infectionBMJ200633275481013101716644828
   PubMed Web of Science ®Google Scholar
• DavisGLAlbrightJECookSFRosenbergDMProjecting future complications of chronic hepatitis C in the United StatesLiver Transpl20039433133812682882
   PubMed Web of Science ®Google Scholar
• StarkGRKerrIMWilliamsBRSilvermanRHSchreiberRDHow cells respond to interferonsAnnu Rev Biochem1998672272649759489
   PubMed Web of Science ®Google Scholar
• BaconBRManaging hepatitis CAm J Manag Care200410Suppl 2S30S4015084065
   PubMed Web of Science ®Google Scholar
• DavisGLEsteban-MurRRustgiVInterferon alfa-2b alone or in combination with ribavirin for the treatment of relapse of chronic hepatitis C. International Hepatitis Interventional Therapy GroupN Engl J Med199833921149314999819447
   PubMed Web of Science ®Google Scholar
• CotlerSJWartelleCFLarsonAMGretchDRJensenDMCarithersRLJrPretreatment symptoms and dosing regimen predict side-effects of interferon therapy for hepatitis CJ Viral Hepat20007321121710849263
   PubMed Web of Science ®Google Scholar
• FosterGMathurinPHepatitis C virus therapy to dateAntivir Ther200813Suppl 1S3S8
   PubMed Web of Science ®Google Scholar
• KowdleyKVHematologic side effects of interferon and ribavirin therapyJ Clin Gastroenterol200539Suppl 1S3S815597025
   PubMed Web of Science ®Google Scholar
• OngJPYounossiZMManaging the hematologic side effects of antiviral therapy for chronic hepatitis C: anemia, neutropenia, and thrombocytopeniaCleve Clin J Med200471Suppl 3S17S2115468613
   PubMedGoogle Scholar
• CapuronLMillerAHCytokines and psychopathology: lessons from interferon-alphaBiol Psychiatry2004561181982415576057
   PubMed Web of Science ®Google Scholar
• DieperinkEWillenbringMHoSBNeuropsychiatric symptoms associated with hepatitis C and interferon alpha: a reviewAm J Psychiatry2000157686787610831463
   PubMed Web of Science ®Google Scholar
• FukunishiKTanakaHMaruyamaJBurns in a suicide attempt related to psychiatric side effects of interferonBurns19982465815839776102
   PubMed Web of Science ®Google Scholar
• JanssenHLBrouwerJTvan der MastRCSchalmSWSuicide associated with alfa-interferon therapy for chronic viral hepatitisJ Hepatol19942122412437989716
   PubMed Web of Science ®Google Scholar
• McHutchisonJGGordonSCSchiffERInterferon alfa-2b alone or in combination with ribavirin as initial treatment for chronic hepatitis C. Hepatitis Interventional Therapy GroupN Engl J Med199833921148514929819446
   PubMed Web of Science ®Google Scholar
• BernsteinDKleinmanLBarkerCMRevickiDAGreenJRelationship of health-related quality of life to treatment adherence and sustained response in chronic hepatitis C patientsHepatology200235370470811870387
   PubMed Web of Science ®Google Scholar
• KrausMRSchaferACsefHFallerHMorkHScheurlenMCompliance with therapy in patients with chronic hepatitis C: associations with psychiatric symptoms, interpersonal problems, and mode of acquisitionDig Dis Sci200146102060206511680576
   PubMed Web of Science ®Google Scholar
• EvonDMRamcharranDBelleSHTerraultNAFontanaRJFriedMWProspective analysis of depression during peginterferon and ribavirin therapy of chronic hepatitis C: results of the Virahep-C studyAm J Gastroenterol2009104122949295819789525
   PubMed Web of Science ®Google Scholar
• KrausMRSchaferASchottkerKTherapy of interferon-induced depression in chronic hepatitis C with citalopram: a randomised, double-blind, placebo-controlled studyGut200857453153618079286
   PubMed Web of Science ®Google Scholar
• GleasonOCFucciJCYatesWRPhilipsenMAPreventing relapse of major depression during interferon-alpha therapy for hepatitis C – a pilot studyDig Dis Sci200752102557256317436092
   PubMed Web of Science ®Google Scholar
• RaisonCLWoolwineBJDemetrashviliMFParoxetine for prevention of depressive symptoms induced by interferon-alpha and ribavirin for hepatitis CAliment Pharmacol Ther200725101163117417451562
   PubMed Web of Science ®Google Scholar
• MorascoBJRifaiMALoftisJMIndestDWMolesJKHauserPA randomized trial of paroxetine to prevent interferon-alpha-induced depression in patients with hepatitis CJ Affect Disord20071031–3839017292481
   PubMed Web of Science ®Google Scholar
• SchaeferMSchwaigerMGarkischASPrevention of interferon-alpha associated depression in psychiatric risk patients with chronic hepatitis CJ Hepatol200542679379815885349
   PubMed Web of Science ®Google Scholar
• SchaeferMSchmidtFFolwacznyCAdherence and mental side effects during hepatitis C treatment with interferon alfa and ribavirin in psychiatric risk groupsHepatology200337244345112540795
   PubMed Web of Science ®Google Scholar
• ParianteCMOrruMGBaitaAFarciMGCarpinielloBTreatment with interferon-alpha in patients with chronic hepatitis and mood or anxiety disordersLancet1999354917313113210408496
   PubMed Web of Science ®Google Scholar
• DantzerRBlutheRMGheusiGMolecular basis of sickness behaviorAnn N Y Acad Sci19988561321389917873
   PubMed Web of Science ®Google Scholar
• DantzerRO’ConnorJCFreundGGJohnsonRWKelleyKWFrom inflammation to sickness and depression: when the immune system subjugates the brainNat Rev Neurosci200891465618073775
   PubMed Web of Science ®Google Scholar
• KonsmanJPParnetPDantzerRCytokine-induced sickness behaviour: mechanisms and implicationsTrends Neurosci200225315415911852148
   PubMed Web of Science ®Google Scholar
• DunnAJSwiergielAHde BeaurepaireRCytokines as mediators of depression: what can we learn from animal studies?Neurosci Biobehav Rev2005294–589190915885777
   PubMed Web of Science ®Google Scholar
• HartBLBiological basis of the behavior of sick animalsNeurosci Biobehav Rev19881221231373050629
   PubMed Web of Science ®Google Scholar
• CharltonBGThe malaise theory of depression: major depressive disorder is sickness behavior and antidepressants are analgesicMed Hypotheses200054112613010790737
   PubMed Web of Science ®Google Scholar
• LotrichFEMajor depression during interferon-alpha treatment: vulnerability and preventionDialogues Clin Neurosci200911441742520135899
   PubMedGoogle Scholar
• SchiepersOJWichersMCMaesMCytokines and major depressionProg Neuropsychopharmacol Biol Psychiatry200529220121715694227
   PubMed Web of Science ®Google Scholar
• BonaccorsoSPuzellaAMarinoVImmunotherapy with interferon-alpha in patients affected by chronic hepatitis C induces an intercorrelated stimulation of the cytokine network and an increase in depressive and anxiety symptomsPsychiatry Res20011051–2455511740974
   PubMed Web of Science ®Google Scholar
• PratherAARabinovitzMPollockBGLotrichFECytokine-induced depression during IFN-alpha treatment: the role of IL-6 and sleep qualityBrain Behav Immun20092381109111619615438
   PubMed Web of Science ®Google Scholar
• LoftisJMHauserPThe phenomenology and treatment of interferon-induced depressionJ Affect Disord200482217519015488246
   PubMed Web of Science ®Google Scholar
• MaddockCLandauSBarryKPsychopathological symptoms during interferon-alpha and ribavirin treatment: effects on virologic responseMol Psychiatry200510433233315655564
   PubMed Web of Science ®Google Scholar
• CapuronLDantzerRMillerAHNeuro-immune interactions in psychopathology with the example of interferon-alpha-induced depressionJ Soc Biol2003197215115612910630
   PubMedGoogle Scholar
• SchaeferMEngelbrechtMAGutOInterferon alpha (IFNalpha) and psychiatric syndromes: a reviewProg Neuropsychopharmacol Biol Psychiatry200226473174612188106
   PubMed Web of Science ®Google Scholar
• TraskPCEsperPRibaMRedmanBPsychiatric side effects of interferon therapy: prevalence, proposed mechanisms, and future directionsJ Clin Oncol200018112316232610829053
   PubMed Web of Science ®Google Scholar
• LoftisJMHuckansMMorascoBJNeuroimmune mechanisms of cytokine-induced depression: current theories and novel treatment strategiesNeurobiol Dis201037351953319944762
   PubMed Web of Science ®Google Scholar
• ElhwuegiASCentral monoamines and their role in major depressionProg Neuropsychopharmacol Biol Psychiatry200428343545115093950
   PubMed Web of Science ®Google Scholar
• OwensMJNemeroffCBRole of serotonin in the pathophysiology of depression: focus on the serotonin transporterClin Chem19944022882957508830
   PubMed Web of Science ®Google Scholar
• MaleticVRobinsonMOakesTIyengarSBallSGRussellJNeurobiology of depression: an integrated view of key findingsInt J Clin Pract200761122030204017944926
   PubMed Web of Science ®Google Scholar
• MiuraHOzakiNSawadaMIsobeKOhtaTNagatsuTA link between stress and depression: shifts in the balance between the kynure-nine and serotonin pathways of tryptophan metabolism and the etiology and pathophysiology of depressionStress200811319820918465467
   PubMed Web of Science ®Google Scholar
• CapuronLNeurauterGMusselmanDLInterferon-alpha-induced changes in tryptophan metabolism. relationship to depression and paroxetine treatmentBiol Psychiatry200354990691414573318
   PubMed Web of Science ®Google Scholar
• BonaccorsoSMarinoVPuzellaAIncreased depressive ratings in patients with hepatitis C receiving interferon-alpha-based immunotherapy are related to interferon-alpha-induced changes in the serotonergic systemJ Clin Psychopharmacol2002221869011799348
   PubMed Web of Science ®Google Scholar
• MaesMBonaccorsoSMarinoVTreatment with interferon-alpha (IFN alpha) of hepatitis C patients induces lower serum dipeptidyl peptidase IV activity, which is related to IFN alpha-induced depressive and anxiety symptoms and immune activationMol Psychiatry20016447548011443537
   PubMed Web of Science ®Google Scholar
• FontanaRJKronfolZLindsayKLChanges in mood states and biomarkers during peginterferon and ribavirin treatment of chronic hepatitis CAm J Gastroenterol2008103112766277518721241
   PubMed Web of Science ®Google Scholar
• RussoSKemaIPHaagsmaEBIrritability rather than depression during interferon treatment is linked to increased tryptophan catabolismPsychosom Med200567577377716204437
   PubMed Web of Science ®Google Scholar
• RaisonCLBorisovASMajerMActivation of central nervous system inflammatory pathways by interferon-alpha: relationship to monoamines and depressionBiol Psychiatry200965429630318801471
   PubMed Web of Science ®Google Scholar
• RaisonCLDantzerRKelleyKWCSF concentrations of brain tryptophan and kynurenines during immune stimulation with IFN-alpha: relationship to CNS immune responses and depressionMol Psychiatry201015439340319918244
   PubMed Web of Science ®Google Scholar
• KrausMRSchaferAFallerHCsefHScheurlenMParoxetine for the treatment of interferon-alpha-induced depression in chronic hepatitis CAliment Pharmacol Ther20021661091109912030950
   PubMed Web of Science ®Google Scholar
• DafnyNYangPBInterferon and the central nervous systemEur J Pharmacol20055231–311516226745
   PubMed Web of Science ®Google Scholar
• AsnisGMde La GarzaR2ndInterferon-induced depression in chronic hepatitis C: a review of its prevalence, risk factors, biology, and treatment approachesJ Clin Gastroenterol200640432233516633105
   PubMed Web of Science ®Google Scholar
• RaisonCLBorisovASBroadwellSDDepression during pegylated interferon-alpha plus ribavirin therapy: prevalence and predictionJ Clin Psychiatry2005661414815669887
   PubMed Web of Science ®Google Scholar
• LeonardBEThe HPA and immune axes in stress: the involvement of the serotonergic systemEur Psychiatry200520Suppl 1S302S30616459240
   PubMed Web of Science ®Google Scholar
• AnismanHCascading effects of stressors and inflammatory immune system activation: implications for major depressive disorderJ Psychiatry Neurosci200934142019125209
   PubMed Web of Science ®Google Scholar
• RaisonCLCapuronLMillerAHCytokines sing the blues: inflammation and the pathogenesis of depressionTrends Immunol2006271243116316783
   PubMed Web of Science ®Google Scholar
• WichersMCKenisGKoekGHRobaeysGNicolsonNAMaesMInterferon-alpha-induced depressive symptoms are related to changes in the cytokine network but not to cortisolJ Psychosom Res200762220721417270579
   PubMed Web of Science ®Google Scholar
• RaisonCLBorisovASWoolwineBJMassungBVogtGMillerAHInterferon-alpha effects on diurnal hypothalamic-pituitary-adrenal axis activity: relationship with proinflammatory cytokines and behaviorMol Psychiatry201015553554718521089
   PubMed Web of Science ®Google Scholar
• MaierSFWatkinsLRCytokines for psychologists: implications of bidirectional immune-to-brain communication for understanding behavior, mood, and cognitionPsychol Rev19981051831079450372
   PubMed Web of Science ®Google Scholar
• BegleyDJThe interaction of some centrally active drugs with the blood-brain barrier and circumventricular organsProg Brain Res1992911631691410401
   PubMed Web of Science ®Google Scholar
• ErmischABrustPKretzschmarRRuhleHJPeptides and blood-brain barrier transportPhysiol Rev19937334895278392735
   PubMed Web of Science ®Google Scholar
• DunnAJEndotoxin-induced activation of cerebral catecholamine and serotonin metabolism: comparison with interleukin-1J Pharmacol Exp Ther199226139649691602402
   PubMed Web of Science ®Google Scholar
• GutierrezEGBanksWAKastinAJMurine tumor necrosis factor alpha is transported from blood to brain in the mouseJ Neuroimmunol19934721691768370768
   PubMed Web of Science ®Google Scholar
• BrownMDWickTMEckmanJRActivation of vascular endothelial cell adhesion molecule expression by sickle blood cellsPediatr Pathol Mol Med2001201477212673844
   PubMed Web of Science ®Google Scholar
• AnismanHMeraliZPoulterMOHayleySCytokines as a precipitant of depressive illness: animal and human studiesCurr Pharm Des200511896397215777247
   PubMed Web of Science ®Google Scholar
• HayleySPoulterMOMeraliZAnismanHThe pathogenesis of clinical depression: stressor- and cytokine-induced alterations of neuroplasticityNeuroscience2005135365967816154288
   PubMed Web of Science ®Google Scholar
• WichersMCKenisGLeueCKoekGRobaeysGMaesMBaseline immune activation as a risk factor for the onset of depression during interferon-alpha treatmentBiol Psychiatry2006601777916487941
   PubMed Web of Science ®Google Scholar
• FranzenPLBuysseDJRabinovitzMPollockBGLotrichFEPoor sleep quality predicts onset of either major depression or subsyndromal depression with irritability during interferon-alpha treatmentPsychiatry Res20101771–224024520381876
   PubMed Web of Science ®Google Scholar
• CaspiASugdenKMoffittTEInfluence of life stress on depression: moderation by a polymorphism in the 5-HTT geneScience2003301563138638912869766
   PubMed Web of Science ®Google Scholar
• BrownGWHarrisTODepression and the serotonin transporter 5-HTTLPR polymorphism: a review and a hypothesis concerning gene-environment interactionJ Affect Disord2008111111218534686
   PubMed Web of Science ®Google Scholar
• HoefgenBSchulzeTGOhlraunSThe power of sample size and homogenous sampling: association between the 5-HTTLPR serotonin transporter polymorphism and major depressive disorderBiol Psychiatry200557324725115691525
   PubMed Web of Science ®Google Scholar
• PezawasLMeyer-LindenbergADrabantEM5-HTTLPR polymorphism impacts human cingulate-amygdala interactions: a genetic susceptibility mechanism for depressionNat Neurosci20058682883415880108
   PubMed Web of Science ®Google Scholar
• BinderEBSalyakinaDLichtnerPPolymorphisms in FKBP5 are associated with increased recurrence of depressive episodes and rapid response to antidepressant treatmentNat Genet200436121319132515565110
   PubMed Web of Science ®Google Scholar
• TadokoroKHashimotoRTatsumiMKosugaAKamijimaKKunugiHThe gem interacting protein (GMIP) gene is associated with major depressive disorderNeurogenetics20056312713316086184
   PubMed Web of Science ®Google Scholar
• HeimanGAOttmanRSaunders-PullmanRJOzeliusLJRischNJBressmanSBIncreased risk for recurrent major depression in DYT1 dystonia mutation carriersNeurology200463463163715326234
   PubMed Web of Science ®Google Scholar
• LemondeSTureckiGBakishDImpaired repression at a 5-hydroxytryptamine 1A receptor gene polymorphism associated with major depression and suicideJ Neurosci200323258788879914507979
   PubMed Web of Science ®Google Scholar
• RosaAPeraltaVPapiolSInterleukin-1beta (IL-1beta) gene and increased risk for the depressive symptom-dimension in schizophrenia spectrum disordersAm J Med Genet B Neuropsychiatr Genet2004124B1101414681906
   PubMed Web of Science ®Google Scholar
• LevinsonDFThe genetics of depression: a reviewBiol Psychiatry2006602849216300747
   PubMed Web of Science ®Google Scholar
• ShynSIHamiltonSPThe genetics of major depression: moving beyond the monoamine hypothesisPsychiatr Clin North Am201033112514020159343
   PubMed Web of Science ®Google Scholar
• BullSJHuezo-DiazPBinderEBFunctional polymorphisms in the interleukin-6 and serotonin transporter genes, and depression and fatigue induced by interferon-alpha and ribavirin treatmentMol Psychiatry200914121095110418458677
   PubMed Web of Science ®Google Scholar
• GocheePAPowellEEPurdieDMAssociation between apolipoprotein E epsilon4 and neuropsychiatric symptoms during interferon alpha treatment for chronic hepatitis CPsychosomatics2004451495714709760
   PubMed Web of Science ®Google Scholar
• KrausMRAl-TaieOSchaferAPfersdorffMLeschKPScheurlenMSerotonin-1A receptor gene HTR1A variation predicts interferon-induced depression in chronic hepatitis CGastroenterology200713241279128617408646
   PubMed Web of Science ®Google Scholar
• LotrichFEFerrellRERabinovitzMPollockBGRisk for depression during interferon-alpha treatment is affected by the serotonin transporter polymorphismBiol Psychiatry200965434434818801474
   PubMed Web of Science ®Google Scholar
• Pierucci-LaghaACovaultJBonkovskyHLA functional serotonin transporter gene polymorphism and depressive effects associated with interferon-alpha treatmentPsychosomatics201051213714820332289
   PubMed Web of Science ®Google Scholar
• SuKPHuangSYPengCYPhospholipase A2 and cyclooxygenase 2 genes influence the risk of interferon-alpha-induced depression by regulating polyunsaturated fatty acids levelsBiol Psychiatry201067655055720034614
   PubMed Web of Science ®Google Scholar
• YoshidaKAlagbeOWangXPromoter polymorphisms of the interferon-alpha receptor gene and development of Interferon-induced depressive symptoms in patients with chronic hepatitis C: preliminary findingsNeuropsychobiology2005522556115990456
   PubMed Web of Science ®Google Scholar
• LotrichFEFerrellRERabinovitzMPollockBGLabile anger during interferon alfa treatment is associated with a polymorphism in tumor necrosis factor alphaClin Neuropharmacol201033419119720661026
   PubMed Web of Science ®Google Scholar
• CasteraLConstantAHenryCImpact on adherence and sustained virological response of psychiatric side effects during peginterferon and ribavirin therapy for chronic hepatitis CAliment Pharmacol Ther20062481223123017014581
   PubMed Web of Science ®Google Scholar
• HorikawaNYamazakiTIzumiNUchiharaMIncidence and clinical course of major depression in patients with chronic hepatitis type C undergoing interferon-alpha therapy: a prospective studyGen Hosp Psychiatry2003251343812583926
   PubMed Web of Science ®Google Scholar
• HauserPKhoslaJAuroraHA prospective study of the incidence and open-label treatment of interferon-induced major depressive disorder in patients with hepatitis CMol Psychiatry20027994294712399946
   PubMed Web of Science ®Google Scholar
• MiyaokaHOtsuboTKamijimaKIshiiMOnukiMMitamuraKDepression from interferon therapy in patients with hepatitis CAm J Psychiatry19991567112010401474
   PubMed Web of Science ®Google Scholar
• Martin-SantosRDiez-QuevedoCCastellviPDe novo depression and anxiety disorders and influence on adherence during peginterferon-alpha-2a and ribavirin treatment in patients with hepatitis CAliment Pharmacol Ther200827325726517988237
   PubMed Web of Science ®Google Scholar
• GohierBGoebJLRannou-DubasKFouchardICalesPGarreJBHepatitis C, alpha interferon, anxiety and depression disorders: a prospective study of 71 patientsWorld J Biol Psychiatry20034311511812872204
   PubMed Web of Science ®Google Scholar
• BonaccorsoSMarinoVBiondiMGrimaldiFIppolitiFMaesMDepression induced by treatment with interferon-alpha in patients affected by hepatitis C virusJ Affect Disord200272323724112450640
   PubMed Web of Science ®Google Scholar
• LotrichFERabinovitzMGirondaPPollockBGDepression following pegylated interferon-alpha: characteristics and vulnerabilityJ Psychosom Res200763213113517662748
   PubMed Web of Science ®Google Scholar
• CapuronLRavaudAMillerAHDantzerRBaseline mood and psychosocial characteristics of patients developing depressive symptoms during interleukin-2 and/or interferon-alpha cancer therapyBrain Behav Immun200418320521315050647
   PubMed Web of Science ®Google Scholar
• LindsayKLDavisGLSchiffERResponse to higher doses of interferon alfa-2b in patients with chronic hepatitis C: a randomized multicenter trial. Hepatitis Interventional Therapy GroupHepatology1996245103410408903371
   PubMed Web of Science ®Google Scholar
• OkanoueTSakamotoSItohYSide effects of high-dose interferon therapy for chronic hepatitis CJ Hepatol19962532832918895006
   PubMed Web of Science ®Google Scholar
• FriedMWShiffmanMLReddyKRPeginterferon alfa-2a plus ribavirin for chronic hepatitis C virus infectionN Engl J Med20023471397598212324553
   PubMed Web of Science ®Google Scholar
• MulderRTAngMChapmanBRossAStevensIFEdgarCInterferon treatment is not associated with a worsening of psychiatric symptoms in patients with hepatitis CJ Gastroenterol Hepatol200215330030310764032
   PubMed Web of Science ®Google Scholar
• RenaultPFHoofnagleJHParkYPsychiatric complications of long-term interferon alfa therapyArch Intern Med19871479157715803307672
   PubMedGoogle Scholar
• MalaguarneraMDi FazioIRestucciaSPistoneGFerlitoLRampelloLInterferon alpha-induced depression in chronic hepatitis C patients: comparison between different types of interferon alphaNeuropsychobiology199837293979566274
   PubMed Web of Science ®Google Scholar
• IinoSHigh dose interferon treatment in chronic hepatitis CGut199334Suppl 2S114S1188314475
   PubMed Web of Science ®Google Scholar
• KrausMRSchaferACsefHScheurlenMPsychiatric side effects of pegylated interferon alfa-2b as compared to conventional interferon alfa-2b in patients with chronic hepatitis CWorld J Gastroenterol200511121769177415793861
   PubMed Web of Science ®Google Scholar
• MannsMPMcHutchisonJGGordonSCPeginterferon alfa-2b plus ribavirin compared with interferon alfa-2b plus ribavirin for initial treatment of chronic hepatitis C: a randomised trialLancet2001358928695896511583749
   PubMed Web of Science ®Google Scholar
• ZeuzemSFeinmanSVRasenackJPeginterferon alfa-2a in patients with chronic hepatitis CN Engl J Med2000343231666167211106715
   PubMed Web of Science ®Google Scholar
• RobaeysGde BieJWichersMCEarly prediction of major depression in chronic hepatitis C patients during peg-interferon alpha-2b treatment by assessment of vegetative-depressive symptoms after four weeksWorld J Gastroenterol200713435736574017963300
   PubMed Web of Science ®Google Scholar
• QuarantiniLCBressanRAGalvaoABatista-NevesSParanaRMiranda-ScippaAIncidence of psychiatric side effects during pegylated interferon- alpha retreatment in nonresponder hepatitis C virus-infected patientsLiver Int20072781098110217845538
   PubMed Web of Science ®Google Scholar
• AmodioPde ToniENCavallettoLMood, cognition and EEG changes during interferon alpha (alpha-IFN) treatment for chronic hepatitis CJ Affect Disord2005841939815620390
   PubMed Web of Science ®Google Scholar
• BanninkMFekkesDvan GoolARInterferon-alpha influences tryptophan metabolism without inducing psychiatric side effectsNeuropsychobiology2007553–422523117873497
   PubMed Web of Science ®Google Scholar
• DonnellySPatient management strategies for interferon alfa-2b as adjuvant therapy of high-risk melanomaOncol Nurs Forum19982559219279644709
   PubMedGoogle Scholar
• CapuronLRavaudAPrediction of the depressive effects of interferon alfa therapy by the patient’s initial affective stateN Engl J Med199934017137010223879
   PubMed Web of Science ®Google Scholar
• CastellviPNavinesRGutierrezFPegylated interferon and ribavirin-induced depression in chronic hepatitis C: role of personalityJ Clin Psychiatry200970681782819573480
   PubMed Web of Science ®Google Scholar
• Dell’OssoLPiniSMaggiLSubthreshold mania as predictor of depression during interferon treatment in HCV+ patients without current or lifetime psychiatric disordersJ Psychosom Res200762334935517324686
   PubMed Web of Science ®Google Scholar
• CasteraLZiganteFBastieABuffetCDhumeauxDHardyPIncidence of interferon alfa-induced depression in patients with chronic hepatitis CHepatology200235497897911915051
   PubMed Web of Science ®Google Scholar
• DieperinkEHoSBThurasPWillenbringMLA prospective study of neuropsychiatric symptoms associated with interferon-alpha-2b and ribavirin therapy for patients with chronic hepatitis CPsychosomatics200344210411212618532
   PubMed Web of Science ®Google Scholar
• HoSBNguyenHTetrickLLOpitzGABasaraMLDieperinkEInfluence of psychiatric diagnoses on interferon-alpha treatment for chronic hepatitis C in a veteran populationAm J Gastroenterol200196115716411197246
   PubMed Web of Science ®Google Scholar
• RaisonCLDemetrashviliMCapuronLMillerAHNeuropsychiatric adverse effects of interferon-alpha: recognition and managementCNS Drugs200519210512315697325
   PubMed Web of Science ®Google Scholar
• DanAAMartinLMCroneCDepression, anemia and health-related quality of life in chronic hepatitis CJ Hepatol200644349149816427157
   PubMed Web of Science ®Google Scholar
• FontanaRJBieliauskasLALindsayKLCognitive function does not worsen during pegylated interferon and ribavirin retreatment of chronic hepatitis CHepatology20074551154116317465000
   PubMed Web of Science ®Google Scholar
• FontanaRJSchwartzSMGebremariamALokASMoyerCAEmotional distress during interferon-alpha-2B and ribavirin treatment of chronic hepatitis CPsychosomatics200243537838512297606
   PubMed Web of Science ®Google Scholar
• HuntCMDominitzJAButeBPWatersBBlasiUWilliamsDMEffect of interferon-alpha treatment of chronic hepatitis C on health-related quality of lifeDig Dis Sci19974212248224869440624
   PubMed Web of Science ®Google Scholar
• KrausMRSchaferAFallerHCsefHScheurlenMPsychiatric symptoms in patients with chronic hepatitis C receiving interferon alfa-2b therapyJ Clin Psychiatry200364670871412823087
   PubMed Web of Science ®Google Scholar
• MaddockCBaitaAOrruMGPsychopharmacological treatment of depression, anxiety, irritability and insomnia in patients receiving interferon-alpha: a prospective case series and a discussion of biological mechanismsJ Psychopharmacol2004181414615107183
   PubMed Web of Science ®Google Scholar
• MajerMWelbergLACapuronLPagnoniGRaisonCLMillerAHIFN-alpha-induced motor slowing is associated with increased depression and fatigue in patients with chronic hepatitis CBrain Behav Immun200822687088018258414
   PubMed Web of Science ®Google Scholar
• SchaferAWittchenHUSeufertJKrausMRMethodological approaches in the assessment of interferon-alfa-induced depression in patients with chronic hepatitis C – a critical reviewInt J Methods Psychiatr Res200716418620118188838
   PubMed Web of Science ®Google Scholar
• YovtchevaSPRifaiMAMolesJKvan der LindenBJPsychiatric comorbidity among hepatitis C-positive patientsPsychosomatics200142541141511739908
   PubMed Web of Science ®Google Scholar
• YatesWRGleasonOHepatitis C and depressionDepress Anxiety1998741881939706456
   PubMedGoogle Scholar
• JohnsonMEFisherDGFenaughtyAThenoSAHepatitis C virus and depression in drug usersAm J Gastroenterol19989357857899625128
   PubMed Web of Science ®Google Scholar
• KenisGPrickaertsJvan OsJDepressive symptoms following interferon-alpha therapy: mediated by immune-induced reductions in brain-derived neurotrophic factor?Int J Neuropsychopharmacol201072917 Epub 2010 Sep 1.
   Web of Science ®Google Scholar
• CapuronLRaisonCLMusselmanDLLawsonDHNemeroffCBMillerAHAssociation of exaggerated HPA axis response to the initial injection of interferon-alpha with development of depression during interferon-alpha therapyAm J Psychiatry200316071342134512832253
   PubMed Web of Science ®Google Scholar
• HeinzeSEgbertsFRotzerSDepressive mood changes and psychiatric symptoms during 12-month low-dose interferon-alpha treatment in patients with malignant melanoma: results from the multicenter DeCOG trialJ Immunother201033110611419952950
   PubMed Web of Science ®Google Scholar
• SockalingamSAbbeySEAlosaimiFNovakMA review of sleep disturbance in hepatitis CJ Clin Gastroenterol2010441384519730115
   PubMed Web of Science ®Google Scholar